StockData

Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/306% above fair value
$546.72−0.03 (-0.01%)

Close on Nov 18, 2026Market cap $7.12BP/E 26.1Yield 0.40%

Chemed free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Chemed's free cash flow for the twelve months ending Sep 30, 2026 was $295.45M, down 18.0% year over year. For fiscal 2025 it was $325.48M, down 11.5% from the year before. Over ten years it grew 9.8% a year on average. The highest annual figure on record is $430.46M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$325.48M-11.5%
FY2024Dec 31, 2024$367.97M+34.6%
FY2023Dec 31, 2023$273.45M+8.3%
FY2022Dec 31, 2022$252.56M+1.1%
FY2021Dec 31, 2021$249.92M-41.9%
FY2020Dec 31, 2020$430.46M+73.4%
FY2019Dec 31, 2019$248.23M+6.0%
FY2018Dec 31, 2018$234.27M+138.6%
FY2017Dec 31, 2017$98.20M+2.7%
FY2016Dec 31, 2016$95.62M-24.9%
FY2015Dec 31, 2015$127.37M+90.9%
FY2014Dec 31, 2014$66.71M-45.1%
FY2013Dec 31, 2013$121.52M+25.9%
FY2012Dec 31, 2012$96.52M-33.3%
FY2011Dec 31, 2011$144.75M+139.8%
FY2010Dec 31, 2010$60.37M-56.7%
FY2009Dec 31, 2009$139.34M+62.0%
FY2008Dec 31, 2008$85.99M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$37.87M-42.5%
Q2 FY2026Jun 30, 2026$69.29M-43.6%
Q1 FY2026Mar 31, 2026$71.10M+265.3%
Q4 FY2025Dec 31, 2025$117.19M-23.0%
Q3 FY2025Sep 30, 2025$65.89M-8.3%
Q2 FY2025Jun 30, 2025$122.80M–
Q1 FY2025Mar 31, 2025$19.46M-73.1%
Q4 FY2024Dec 31, 2024$152.15M+57.2%
Q3 FY2024Sep 30, 2024$71.87M+316.1%
Q2 FY2024Jun 30, 2024-$18.91M-116.3%
Q1 FY2024Mar 31, 2024$72.39M+66.5%
Q4 FY2023Dec 31, 2023$96.78M+18.1%
Q3 FY2023Sep 30, 2023$17.27M-55.2%
Q2 FY2023Jun 30, 2023$115.92M+165.7%
Q1 FY2023Mar 31, 2023$43.47M-50.8%
Q4 FY2022Dec 31, 2022$81.94M+66.0%
Q3 FY2022Sep 30, 2022$38.56M-62.2%
Q2 FY2022Jun 30, 2022$43.62M+363.4%
Q1 FY2022Mar 31, 2022$88.44M-0.7%
Q4 FY2021Dec 31, 2021$49.37M-30.2%
Q3 FY2021Sep 30, 2021$102.12M-10.6%
Q2 FY2021Jun 30, 2021$9.41M-94.7%
Q1 FY2021Mar 31, 2021$89.02M+28.2%
Q4 FY2020Dec 31, 2020$70.72M+40.5%
Q3 FY2020Sep 30, 2020$114.17M-2.7%
Q2 FY2020Jun 30, 2020$176.14M+743.8%
Q1 FY2020Mar 31, 2020$69.43M+16.3%
Q4 FY2019Dec 31, 2019$50.34M+25.2%
Q3 FY2019Sep 30, 2019$117.30M+21.1%
Q2 FY2019Jun 30, 2019$20.88M-53.2%
Q1 FY2019Mar 31, 2019$59.72M+13.7%
Q4 FY2018Dec 31, 2018$40.21M–
Q3 FY2018Sep 30, 2018$96.89M+41.3%
Q2 FY2018Jun 30, 2018$44.62M+259.1%
Q1 FY2018Mar 31, 2018$52.55M-12.1%
Q4 FY2017Dec 31, 2017-$42.55M–
Q3 FY2017Sep 30, 2017$68.55M–
Q2 FY2017Jun 30, 2017$12.43M–
Q1 FY2017Mar 31, 2017$59.77M–
Q4 FY2016Dec 31, 2016-$3.02M–

More Chemed figures

See a number that looks wrong?